GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA1A, ADRA2A, AKR1B1, APEX1, AURKB, AXL, BCL2, CA12, CA2, CA7, CDK6, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, F10, F3, FABP3, FABP4, FLT3, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR7, KCNH2, KDR, MET, PIK3CA, PIK3CB, POLA1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PTGS1, PTGS2, SLC22A1, SLC22A2, SLC22A3, SLC6A2, SLC6A4, SRC, TERT, TNKS, TNKS2, TRPV1, XDH |
14.6739 |
[BP] GO:0042221 |
response to chemical
|
ADRA1A, ADRA2A, AKR1B1, ALPL, APEX1, AXL, BCL2, CA2, CA9, CDK6, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HTR2A, HTR2B, HTR5A, IGF1R, KCNH2, KDR, MMP2, MMP9, PIK3CA, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, RORC, SLC6A2, SLC6A4, SRC, TERT, TRPV1, TYR |
12.8727 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, HTR5A, IGF1R, MMP2, MMP9, PIK3CA, POLB, PPARA, PRKCB, PRKCD, PRKCE, PTGS2, RORC, SLC6A4, SRC, TRPV1, TYR |
11.8206 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD2, ESR1, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, TBXAS1, TRPV1 |
11.8206 |
[BP] GO:0042493 |
response to drug
|
ADRA1A, AKR1B1, APEX1, AXL, BCL2, CA9, CDK6, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, FABP3, HSD11B2, HTR2A, HTR2B, KCNH2, KDR, POLB, PRKCD, PRKCE, PRKCG, PTGS2, SLC6A2, SLC6A4, SRC, TRPV1 |
11.3324 |
[BP] GO:0010033 |
response to organic substance
|
ADRA1A, ADRA2A, AKR1B1, ALPL, APEX1, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HTR5A, IGF1R, KDR, MMP2, PIK3CA, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, RORC, SLC6A4, SRC, TRPV1, TYR |
11.3324 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FLT3, HCAR2, HTR2A, HTR2B, HTR6, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
11.0746 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FLT3, HCAR2, HTR2A, HTR2B, HTR6, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
11.05 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.3056 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FLT3, HSD11B2, HTR5A, PRKCE, PRKCG, PTGS2, RORC, SLC6A4, SRC, TRPV1, TYR |
9.8385 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADRA2A, AURKB, BCL2, CA2, CA7, CDK6, DRD1, DRD2, DRD3, HCAR2, HTR2A, HTR2B, KDR, PIK3CB, PRKCE, PTGS2, SRC, TNKS, TNKS2, TRPV1 |
9.8385 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TYR |
9.71027 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGS1, PTGS2, TBXAS1 |
9.70431 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
9.59942 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGS1, PTGS2, TBXAS1 |
9.54513 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP2D6, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
9.45761 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGS1, PTGS2, TBXAS1 |
9.44249 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, FUT7, GBA2, GLO1, HTR2B, PIK3CA, PIM1, PPARA, PTGS1, PTGS2, TBXAS1, TYR, XDH |
9.37687 |
[BP] GO:0009725 |
response to hormone
|
ADRA1A, ADRA2A, AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HTR5A, PPARA, PRKCD, PRKCE, PTGS2, SLC6A4, SRC, TRPV1 |
9.13621 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2B, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC22A2, SLC6A4, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH |
9.08324 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, F10, F3, FLT3, HTR2A, HTR2B, HTR6, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
8.75082 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA6, CA9, CDK6, CES1, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, F10, F3, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, IGF1R, KCNH2, KDR, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, POLA1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, SRC, TERT, TOP2A, TRPV1, TYR |
8.7443 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA1A, ADRA2A, AKR1B1, APEX1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH |
8.47738 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, FABP3, PPARA, SLC22A1, SLC22A2, SLC22A3, TRPV1 |
8.13791 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA1A, ADRA2A, AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DRD1, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HTR5A, IGF1R, MMP2, PPARA, PRKCD, PRKCE, PTGS2, SLC6A4, SRC, TRPV1 |
8.09973 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, HCAR2, HTR2B, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SIGMAR1, SRC, TERT, TOP2A, TRPV1, XDH |
8.08343 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, DRD2, DRD3, ESR1, ESRRA, F3, FABP3, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PRKCA, PTGS1, PTGS2, SLC6A4, SRC, TERT, XDH |
7.97393 |
[BP] GO:0015872 |
None
|
DRD1, SLC22A1, SLC22A2, SLC22A3, SLC6A2, SLC6A4 |
7.96731 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, HCAR2, HTR2B, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SIGMAR1, SRC, TERT, TOP2A, TRPV1, XDH |
7.95866 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, APEX1, AXL, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, ESR1, FABP3, FABP4, FLT3, HTR2A, HTR2B, KCNH2, MET, PIK3CA, PIK3CB, POLA1, POLB, PRKCB, PRKCE, SRC, TERT, TRPV1 |
7.91121 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, CYP2D6, NQO2, PTGS1, RORC |
7.8367 |
[BP] GO:0097756 |
None
|
ADORA1, ADRA1A, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4 |
7.83462 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADRA2A, AKR1B1, CYP19A1, CYP1A1, CYP1B1, DRD2, ESR1, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A, PRKCA, PRKCE, SLC22A1 |
7.78982 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, HTR5A, PRKCE, PTGS2, RORC, SLC6A4, SRC, TYR |
7.71458 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGS1, PTGS2, TBXAS1 |
7.66726 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HSD17B1, HSD17B2, HTR1A, HTR2B, IGF1R, KCNH2, KDR, MET, MMP1, MMP2, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC22A2, SLC6A4, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
7.63827 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CES1, CES2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD2, FABP3, FABP4, FUT7, GBA2, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, TBXAS1 |
7.63581 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, HCAR2, HTR2B, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SIGMAR1, SRC, TERT, TOP2A, TRPV1, XDH |
7.62566 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CES1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, KDR, POLB, PRKCD, PRKCE, SLC6A4, SRC |
7.60434 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, AXL, BCL2, CYP1B1, DRD2, F10, F3, FLT3, HTR2A, HTR2B, HTR6, KDR, MET, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCE, PTGS2, PTPN1, SRC, XDH |
7.5592 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, PPARA, PTGS1, PTGS2, TBXAS1 |
7.5592 |
[BP] GO:0051937 |
None
|
DRD1, SLC22A1, SLC22A2, SLC22A3, SLC6A2, SLC6A4 |
7.41208 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, HTR2B, KDR, PRKCE, SRC, TRPV1 |
7.40789 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ADRA2A, APEX1, AXL, BCL2, CA2, CA7, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, HCAR2, HTR1A, HTR2A, HTR2B, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, PIK3CB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SLC6A4, SRC, TERT, TRPV1 |
7.40789 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, ESRRA, F10, F3, FABP4, FLT3, HTR2A, HTR2B, HTR6, KDR, MET, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
7.40789 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGS1, PTGS2, TBXAS1 |
7.23499 |
[BP] GO:0006811 |
None
|
ADRA1A, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, DRD3, FABP3, HTR2A, HTR2B, KCNH2, PPARA, PRKCB, PRKCE, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC6A2, SLC6A4, TRPV1 |
7.10534 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, DRD2, DRD3, ESR1, F3, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PRKCA, PTGS2, TERT |
6.95245 |
[BP] GO:0032845 |
None
|
ADORA1, ADRA2A, BCL2, DRD2, HTR2A, HTR2B, PRKCE, SRC, TNKS, TNKS2, TRPV1 |
6.9264 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA1A, ADRA2A, AKR1B1, APEX1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH |
6.88767 |
[BP] GO:0030168 |
platelet activation
|
ADRA2A, AXL, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
6.87665 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, HSD11B1, HSD11B2, HSD17B1, HSD17B2, NQO2, PTGS1, PTGS2, TBXAS1, TYR, XDH |
6.87665 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, POLB, PPARA, PRKCB, PRKCE, PTGS2, SLC6A4, SRC, TERT |
6.73439 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4, SRC |
6.63324 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, FABP3, PPARA, SLC22A1, SLC22A2, SLC22A3, TRPV1 |
6.6184 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, AKR1B10, ALOX5, ALPL, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRB, F10, F3, FABP4, HSD11B2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR7, IGF1R, KCNH2, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, PPARA, PRKCD, PRKCG, PTGS2, RORC, SLC6A2, SLC6A4, SRC, TNKS2, TRPV1, TYR |
6.61043 |
[BP] GO:0032787 |
None
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, GBA2, GLO1, PPARA, PTGS1, PTGS2, TBXAS1 |
6.61043 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, ALPL, APEX1, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KCNH2, KDR, MMP2, MMP9, PIK3CA, PRKCB, PRKCD, PRKCE, PTGS2, RORC, SLC6A4, SRC, TERT, TRPV1 |
6.57952 |
[BP] GO:0015844 |
None
|
DRD1, SLC22A1, SLC22A2, SLC22A3, SLC6A2, SLC6A4 |
6.53662 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19 |
6.53662 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, ADRA2A, CYP1A1, DRD3, FABP3, FLT3, HCAR2, HTR2A, HTR2B, PPARA, PRKCD, PRKCE, PTGS2, RORC, SRC |
6.49744 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, ESR1, F10, F3, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
6.46005 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4 |
6.45131 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4 |
6.45131 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA1A, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, F10, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
6.43811 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PRKCB, PRKCE, PTGS2, SLC6A4, SRC, TERT |
6.40718 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CDC25B, CDK6, CES1, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD17B2, HTR2A, HTR2B, HTR5A, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, POLB, PPARA, PRKCA, PRKCD, PTGS2, RORC, SIGMAR1, SLC6A4, SRC, TERT, TNKS2, TOP2A, TYR |
6.29967 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ADRA2A, APEX1, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC, TERT |
6.27343 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PRKCB, PRKCE, PTGS2, SLC6A4, SRC, TERT |
6.27286 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4 |
6.23108 |
[BP] GO:0007210 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.23108 |
[BP] GO:0098664 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.23108 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4 |
6.21264 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA1A, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, F10, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
6.17667 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ADRA2A, APEX1, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC, TERT |
6.17096 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, AURKB, BCL2, CA2, CYP1A1, DRD1, DRD2, DRD3, HSD11B2, HTR2A, HTR2B, MMP2, POLB, PPARA, PRKCB, PRKCE, PTGS2, SLC6A4, SRC, TERT, TRPV1, TYR |
6.0858 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MMP9, PRKCD, PTGS2, SRC, TERT |
6.06217 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CDK6, CYP1B1, DRD1, KCNH2, KDR, PRKCD, PRKCE, PTGS2, SRC, TRPV1 |
6.03412 |
[BP] GO:0007187 |
None
|
ADORA1, ADRA1A, ADRA2A, CHRM2, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR6, HTR7 |
6.01433 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, DRD3, ESR1, HTR7, PPARA, PRKCG, RORC, SLC6A4, SRC, TOP2A |
6.00469 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, ADRA2A, BCL2, DRD2, DRD3, HTR2A, KCNH2, MMP9, PRKCE, PTGS2 |
6.00013 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, FLT3, HTR2B, IGF1R, KCNH2, KDR, MET, PIK3CA, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TNKS |
5.94073 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ADRA2A, APEX1, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC, TERT |
5.91627 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, ALPL, APEX1, AXL, BCL2, CDK6, CYP1A1, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, PIK3CA, PRKCB, PRKCD, PRKCE, PTGS2, RORC, SLC6A4, SRC, TRPV1 |
5.88791 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA1A, ADRA2A, AKR1B1, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, ESR1, FABP3, FABP4, HTR2A, HTR2B, KCNH2, MET, PIK3CA, PIK3CB, PRKCB, PRKCE, TRPV1 |
5.88453 |
[BP] GO:0006939 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7, TRPV1 |
5.8801 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, HTR2B, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PPARA, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SRC, TERT |
5.83356 |
[BP] GO:0007193 |
None
|
ADORA1, ADRA2A, CHRM2, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
5.82224 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, HTR2B, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SRC, TERT |
5.81175 |
[BP] GO:0042310 |
None
|
ADRA1A, HTR1A, HTR2A, HTR2B, HTR7, SLC6A4 |
5.76283 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ADRA2A, AXL, BCL2, CA2, CA7, CYP19A1, DRD1, DRD2, DRD3, HCAR2, HTR1A, HTR2A, HTR2B, KCNH2, MMP12, MMP9, PIK3CB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SLC6A4, SRC, TERT, TRPV1 |
5.75584 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA1A, ADRA2A, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH |
5.72038 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, APEX1, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, HTR2A, HTR2B, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, PIK3CA, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH |
5.6622 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA1A, ADRA2A, CHRM2, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
5.62172 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ADRA2A, APEX1, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC, TERT |
5.61808 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, DRD3, HTR1A, PTGS2, SLC22A2, SLC22A3, SLC6A2, SLC6A4, TRPV1 |
5.58831 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4, SRC |
5.56292 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3, PTGS2, SLC6A4 |
5.52373 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, ADRA1A, CA2, CA7, DRD2, PRKCE |
5.52078 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, ADRA2A, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, HTR2A, HTR2B, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
5.41739 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA1A, ADRA2A, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, HTR2A, HTR2B, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
5.41739 |
[BP] GO:0018105 |
peptidyl-serine phosphorylation
|
AURKB, BCL2, DRD1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TNKS |
5.41739 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, PPARA, PRKCD, PRKCE, PTGS2, SRC |
5.41576 |
[BP] GO:0007200 |
None
|
ADRA1A, ADRA2A, CHRM2, DRD1, DRD2, ESR1, HTR2A, HTR2B |
5.40788 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, AXL, CDK6, CYP1B1, DRD1, ESR1, IGF1R, MMP2, MMP9, PIK3CA, PRKCB, PRKCD, PRKCE, PTGS2, RORC, SLC6A4, SRC, TRPV1 |
5.40788 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.36092 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.36092 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, DRD1, DRD2, DRD3, FABP3, FLT3, HSD11B2, IGF1R, MMP2, PPARA, PRKCD, PRKCE, PRKCG, PTGS2, SLC6A4, SRC, TRPV1, TYR |
5.35904 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA1A, ADRA2A, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH |
5.34641 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APEX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DRD2, FLT3, HTR2B, IGF1R, KCNH2, KDR, MET, PIK3CA, PIK3CB, PIM1, POLB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TNKS, XDH |
5.27811 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, HTR2B, IGF1R, KDR, MMP9, PIK3CA, PIM1, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SRC, TERT |
5.27811 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA1A, ADRA2A, AURKB, BCL2, CDC25B, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH |
5.19402 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, DRD3, HCAR2, PIK3CB, PTGS2, TNKS, TNKS2 |
5.18436 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA1A, ADRA2A, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
5.16145 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, ADRA2A, AXL, BCL2, CA2, CYP19A1, DRD1, DRD2, DRD3, HCAR2, HTR2B, KCNH2, MMP12, PRKCD, PRKCE, PTGS2, SLC6A4, SRC, TERT, TRPV1 |
5.1266 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, FLT3, HTR2B, IGF1R, KCNH2, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TNKS |
5.10721 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2, HTR2A, PTGS2, SLC6A4 |
5.09034 |
[BP] GO:0018209 |
peptidyl-serine modification
|
AURKB, BCL2, DRD1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TNKS |
5.02096 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
5.00152 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KCNH2, KDR, MMP2, MMP9, PIK3CA, POLA1, POLB, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, TOP2A, TRPV1 |
4.95028 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA1A, ADRA2A, BCL2, CDC25B, DRD2, ESRRB, FLT3, HTR2A, HTR2B, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.94767 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, PRKCE, PTGS2, SLC6A4 |
4.88977 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, PRKCE, PTGS2, SLC6A4 |
4.88977 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, DRD1, DRD2, DRD3, FABP3, FLT3, HSD11B2, IGF1R, MMP2, PPARA, PRKCD, PRKCE, PRKCG, PTGS2, SLC6A4, SRC, TRPV1, TYR |
4.88277 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, AXL, BCL2, CA1, CA2, CDK6, CHRM2, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SIGMAR1, SRC, TNKS, TNKS2, TRPV1 |
4.88109 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APEX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DRD2, FLT3, HTR2B, IGF1R, KCNH2, KDR, MET, PIK3CA, PIK3CB, PIM1, POLB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TNKS, XDH |
4.87124 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, PRKCD, SRC |
4.80726 |
[BP] GO:0015893 |
None
|
CA2, DRD1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SLC6A2, SLC6A4 |
4.80256 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, BCL2, DRD1, F10, F3, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC, TERT |
4.76696 |
[BP] GO:0050801 |
ion homeostasis
|
ADRA1A, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, ESR1, FABP3, HTR2A, HTR2B, KCNH2, PIK3CB, PRKCB, PRKCE, TRPV1 |
4.76696 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA1A, ADRA2A, AKR1B1, AXL, BCL2, CYP1B1, DRD1, DRD2, DRD3, HTR2A, HTR2B, HTR5A, IGF1R, KCNH2, KDR, MET, PIK3CA, PIK3CB, POLB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SRC |
4.72056 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, APEX1, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, HCAR2, HTR2A, HTR2B, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, PIK3CA, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH |
4.69463 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
4.66844 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA1A, ADRA2A, BCL2, CDC25B, DRD2, FLT3, HTR2A, HTR2B, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.6297 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, GBA2, GLO1, PIM1, PPARA, PTGS1, PTGS2, TBXAS1, TYR |
4.61182 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, ADRA2A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, HTR1A, HTR2A, KCNH2, MMP9, PRKCD, PRKCE, PTGS2, SLC6A4 |
4.60099 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, BCL2, DRD1, F10, F3, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC, TERT |
4.59867 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, DRD3, HTR1A, TYR |
4.55275 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR2B, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH |
4.54858 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, F10, F3, MET, PIK3CA, PIK3CB, SRC, XDH |
4.53591 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AXL, BCL2, CA2, CDK6, CHRM2, CYP1B1, DRD2, DRD3, ESR1, ESRRA, ESRRB, F3, HCAR2, HTR2A, HTR2B, KCNH2, KDR, MET, MMP12, MMP9, PIK3CA, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, SLC6A4, SRC, TERT, TNKS2, TRPV1, XDH |
4.52877 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, HTR2A, MET, PIK3CA, TRPV1 |
4.50104 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ADRA2A, BCL2, DRD1, F10, F3, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC, TERT |
4.47926 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, ADRA2A, AURKB, CSNK2A1, CYP1B1, CYP2D6, DRD2, DRD3, ESR1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TNKS |
4.46527 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, PRKCE, PTGS2 |
4.42372 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA1A, ADRA2A, BCL2, DRD1, DRD2, DRD3, ESR1, ESR2, HTR2A, IGF1R, MET, MMP12, MMP9, PRKCB, PRKCD, PTGS2, PTPN1, SLC6A4, SRC, TERT, XDH |
4.37069 |
[BP] GO:0050994 |
None
|
ADORA1, ADRA2A, HCAR2, PPARA, PRKCD, PRKCE |
4.3668 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2B, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH |
4.36658 |
[BP] GO:0016572 |
histone phosphorylation
|
AURKB, DRD1, PRKCA, PRKCB, PRKCD |
4.36076 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA1A, ADRA2A, BCL2, DRD1, DRD2, DRD3, ESR1, ESR2, HTR2A, IGF1R, MET, MMP12, MMP9, PRKCB, PRKCD, PTGS2, PTPN1, SLC6A4, SRC, TERT, XDH |
4.35787 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
ADRA1A, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, KCNH2, PIK3CB, PRKCB, PRKCE, TRPV1 |
4.33703 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, BCL2, CES1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, GBA2, HTR1A, TYR |
4.33336 |
[BP] GO:0015696 |
None
|
DRD1, SLC22A1, SLC22A2, SLC22A3, SLC6A2, SLC6A4 |
4.33197 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA1A, ADRA2A, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.33197 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ADRA2A, BCL2, DRD1, F10, F3, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC, TERT |
4.32427 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APEX1, CYP1A1, CYP1B1, DRD1, ESR1, FLT3, PTGS2, RORC, SLC6A4, SRC, TRPV1 |
4.27783 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA1A, ADRA2A, BCL2, CDC25B, DRD1, DRD2, DRD3, ESRRB, FABP3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.27783 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, ADRA2A, APEX1, BCL2, CSNK2A1, ESRRB, HCAR2, HTR2A, HTR2B, KDR, MET, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTPN1 |
4.26941 |
[BP] GO:0007568 |
aging
|
ADRA1A, APEX1, AURKB, BCL2, CYP1A1, HTR2A, POLB, PRKCD, PTGS2, TERT |
4.23444 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADRA1A, CA2, CA7, PRKCE |
4.22791 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, ADRA2A, BCL2, CDC25B, DRD1, DRD2, DRD3, ESRRB, FABP3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.22131 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA1A, ADRA2A, AXL, BCL2, CA2, CYP1B1, DRD2, DRD3, ESRRB, F3, HCAR2, HTR2A, HTR2B, KDR, MET, MMP12, MMP9, PIM1, PRKCA, PRKCB, PRKCE, PTGS2, SRC, TERT, TRPV1 |
4.20418 |
[BP] GO:0007198 |
None
|
HTR1A, HTR5A, HTR7 |
4.20418 |
[BP] GO:0015874 |
None
|
SLC22A1, SLC22A2, SLC6A2 |
4.20418 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.20418 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2, HTR2A, TRPV1 |
4.17767 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB |
4.17767 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA1A, ADRA2A, DRD2, FLT3, HTR2A, HTR2B, KDR, PIK3CB, PRKCA, PRKCE, PTPN1, SRC, XDH |
4.12167 |
[BP] GO:0090066 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, HTR1A, HTR2A, HTR2B, HTR7, PRKCD, PRKCE, PTGS2, SLC6A4 |
4.08761 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, F10, F3, FABP4, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
4.08112 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, GBA2, GLO1, PIM1, PPARA, PTGS1, PTGS2, TBXAS1, TYR |
4.06853 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.02062 |
[BP] GO:0042752 |
None
|
ADORA1, DRD2, DRD3, PPARA, PRKCG, RORC, TOP2A |
3.98313 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, GBA2, GLO1, PIM1, PPARA, PTGS1, PTGS2, TBXAS1, TYR |
3.96112 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, PIK3CB, PRKCB, PRKCE, TRPV1 |
3.95492 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, HCAR2, HTR2B, MMP12, PRKCE, SLC6A4, SRC, TRPV1 |
3.94485 |
[BP] GO:0019725 |
cellular homeostasis
|
ADRA1A, APEX1, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, PIK3CA, PIK3CB, POLA1, PRKCB, PRKCE, TRPV1 |
3.92454 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DRD1, F10, FLT3, IGF1R, KDR, MET, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TNKS, TOP2A |
3.92365 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA1A, ADRA2A, BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
3.91724 |
[BP] GO:0050795 |
None
|
ADORA1, DRD2, DRD3, HTR1A, HTR2A, HTR2B |
3.9123 |
[BP] GO:0060402 |
None
|
ADRA1A, DRD2, HTR2A, HTR2B, PRKCE, TRPV1 |
3.9123 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, ESR1, ESR2, F10, F3, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
3.83769 |
[BP] GO:0008217 |
None
|
ADORA1, ADRA1A, DRD2, DRD3, HSD11B2, PPARA, PTGS1, PTGS2 |
3.83447 |
[BP] GO:0048513 |
animal organ development
|
ACHE, ADRA1A, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, KDR, PIK3CA, POLB, PPARA, SRC, TYR |
3.83344 |
[BP] GO:0055074 |
calcium ion homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, PIK3CB, PRKCB, PRKCE, TRPV1 |
3.83247 |
[BP] GO:0032467 |
None
|
AURKB, CDC25B, DRD2, DRD3, PRKCE |
3.82388 |
[BP] GO:0055080 |
cation homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, KCNH2, PIK3CB, PRKCB, PRKCE, TRPV1 |
3.81978 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA1A, ADRA2A, DRD2, FLT3, HTR2A, HTR2B, IGF1R, KDR, PIK3CB, PRKCA, PRKCD, PRKCE, PTPN1, SRC, XDH |
3.79026 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, PIK3CB, PRKCB, PRKCE, TRPV1 |
3.78245 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, HSD11B2, HTR1A, MMP2, MMP9, PIK3CA, PIK3CB, POLA1, POLB, PPARA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, SLC6A2, SLC6A4, SRC, TERT, TOP2A, TRPV1 |
3.781 |
[BP] GO:0003012 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7, KCNH2, PIK3CA, TRPV1 |
3.781 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CES1, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PIK3CA, PIK3CB, PTGS1, PTGS2 |
3.77026 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, PRKCD, SRC |
3.73861 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
3.73861 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, PRKCD, SRC |
3.73861 |
[BP] GO:0072488 |
None
|
SLC22A1, SLC22A2, SLC22A3, SLC6A4 |
3.68418 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, ADRA2A, CYP19A1, DRD2, DRD3, HCAR2, HTR1A, HTR2A, HTR2B, MMP12, PRKCA, PRKCE, SLC6A4, SRC, TRPV1 |
3.68392 |
[BP] GO:0030003 |
cellular cation homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, PIK3CB, PRKCB, PRKCE, TRPV1 |
3.65735 |
[BP] GO:0006936 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7, KCNH2, PIK3CA, TRPV1 |
3.64469 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, PRKCD, SRC |
3.64469 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, PIK3CA, PIK3CB, PRKCB, PRKCE, TRPV1 |
3.63895 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, PIK3CB, PRKCB, PRKCE, TRPV1 |
3.58852 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP2C19, CYP2D6 |
3.58852 |
[BP] GO:0006873 |
cellular ion homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, PIK3CB, PRKCB, PRKCE, TRPV1 |
3.54463 |
[BP] GO:0051952 |
None
|
ADORA1, ADRA2A, DRD1, DRD2, DRD3, HTR2A |
3.51621 |
[BP] GO:0060401 |
None
|
ADRA1A, DRD2, HTR2A, HTR2B, PRKCE, TRPV1 |
3.51621 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3, HTR2A |
3.50958 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADRA2A, APEX1, AURKB, BCL2, CSNK2A1, CYP2D6, DRD2, DRD3, ESR1, ESR2, ESRRA, FABP4, HCAR2, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TRPV1, XDH |
3.50958 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR, PRKCD, PRKCE |
3.45892 |
[BP] GO:0018107 |
peptidyl-threonine phosphorylation
|
BCL2, CSNK2A1, PRKCA, PRKCB, PRKCD, TNKS |
3.45801 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, F3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TERT, TNKS, TRPV1, XDH |
3.45427 |
[BP] GO:0051209 |
None
|
DRD2, HTR2A, HTR2B, PRKCE, TRPV1 |
3.44237 |
[BP] GO:0051283 |
None
|
DRD2, HTR2A, HTR2B, PRKCE, TRPV1 |
3.44237 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA1A, ADRA2A, BCL2, CDK6, CYP19A1, DRD1, DRD2, DRD3, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, PPARA, PRKCB, PRKCD, PTGS2, PTPN1, SRC, TERT, XDH |
3.43548 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, ADRA2A, CYP19A1, DRD2, DRD3, HCAR2, HTR1A, HTR2A, HTR2B, MMP12, PRKCA, PRKCE, SLC6A4, SRC |
3.43548 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
ADRA1A, BCL2, DRD2, DRD3, ESR1, IGF1R, MET, MMP9, PRKCD, PTGS2, PTPN1, SRC, XDH |
3.40496 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, MMP9, PRKCD, SRC |
3.39483 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, ESR1, F3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TERT, TNKS, XDH |
3.39244 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA1A, ADRA2A, CHRM2, DRD2, DRD3, HCAR2, HTR2A, KCNH2, PRKCA, PTGS2, TRPV1 |
3.39244 |
[BP] GO:0003008 |
None
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, BCL2, CYP1B1, DRD1, DRD2, DRD3, HSD11B2, HTR1A, HTR2A, HTR2B, HTR7, KCNH2, PIK3CA, PRKCG, PTGS2, SLC6A4, SRC, TRPV1, TYR |
3.39244 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, RORC, SRC |
3.38254 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, ESR1, F3, FABP4, KDR, MET, MMP12, PPARA, PRKCA, PRKCD, PRKCG, PTGS2 |
3.36446 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC |
3.36446 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, ADRA1A, ADRA2A, CA2, CHRM2, DRD1, DRD2, DRD3, ESR1, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, PIK3CA, PIK3CB, SIGMAR1, SRC |
3.34457 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CES1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.34457 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APEX1, AURKB, CDC25B, CYP1A1, DRD2, DRD3, PRKCA, PRKCE, SLC6A4, SRC, TERT |
3.33914 |
[BP] GO:1904063 |
None
|
ADRA2A, DRD2, DRD3, KCNH2, MMP9, PRKCE |
3.3279 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3 |
3.3244 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA1A, ADRA2A, AURKB, BCL2, CDC25B, DRD2, ESR1, ESR2, F3, FLT3, HTR2A, HTR2B, MET, MMP9, PIK3CA, PIK3CB, PRKCB, PRKCD, PRKCE, PTPN1, SRC, TERT, TNKS, XDH |
3.32347 |
[BP] GO:0051781 |
None
|
AURKB, CDC25B, DRD2, DRD3, HTR2B, PRKCE |
3.30205 |
[BP] GO:0018210 |
peptidyl-threonine modification
|
BCL2, CSNK2A1, PRKCA, PRKCB, PRKCD, TNKS |
3.27364 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2, DRD3, HTR1A |
3.27352 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.26678 |
[BP] GO:0071702 |
None
|
ADORA1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, DRD3, FABP3, MMP12, PPARA, PRKCB, SIGMAR1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC6A2, SLC6A4, TNKS, TRPV1 |
3.23937 |
[BP] GO:0007610 |
None
|
BCL2, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, PPARA, PRKCE, PRKCG, PTGS2, SLC6A4, TRPV1 |
3.22988 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.22148 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA1A, ADRA2A, BCL2, CDC25B, DRD2, FLT3, HTR2A, HTR2B, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
3.22148 |
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3 |
3.20243 |
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3 |
3.20243 |
[BP] GO:0055065 |
metal ion homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, KCNH2, PIK3CB, PRKCB, PRKCE, TRPV1 |
3.19423 |
[BP] GO:0019933 |
None
|
ADRA1A, ADRA2A, DRD1, DRD2, DRD3, HTR5A |
3.11651 |
[BP] GO:0051179 |
None
|
ACHE, ADORA1, ADRA1A, ADRA2A, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, DRD3, ESR1, F10, FABP3, HTR2A, HTR2B, KCNH2, MMP12, MMP9, PPARA, PRKCB, PRKCD, PRKCE, SIGMAR1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SLC6A2, SLC6A4, SRC, TERT, TNKS, TNKS2, TRPV1, XDH |
3.11189 |
[BP] GO:0033555 |
multicellular organismal response to stress
|
BCL2, DRD1, HTR1A, PRKCG, SLC6A2 |
3.09053 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADRA2A, APEX1, AURKB, BCL2, CSNK2A1, CYP2D6, DRD2, DRD3, ESR1, ESR2, ESRRA, FABP4, HTR2B, IGF1R, MET, MMP12, MMP9, PIK3CA, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TRPV1, XDH |
3.08695 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
AURKB, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, PPARA, PRKCD, PTGS2, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1 |
3.07444 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ADRA2A, CDK6, CYP19A1, DRD2, ESR1, F3, FABP4, IGF1R, MET, MMP12, MMP2, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TERT, XDH |
3.06484 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CDK6, CES1, CES2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HCAR2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SIGMAR1, SLC22A1, SLC22A2, SLC6A2, SLC6A4, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH |
3.06484 |
[BP] GO:0050878 |
regulation of body fluid levels
|
ADORA1, AKR1B1, DRD2, F10, F3, MET, PRKCA, PRKCD, PRKCE, SLC22A2, XDH |
3.06484 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, PRKCG, SRC |
3.06394 |
[BP] GO:0006810 |
None
|
ACHE, ADORA1, ADRA1A, ADRA2A, ALOX5, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, DRD3, F10, FABP3, HTR2A, HTR2B, KCNH2, MMP12, MMP9, PPARA, PRKCB, PRKCD, PRKCE, SIGMAR1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SLC6A2, SLC6A4, SRC, TNKS, TRPV1, XDH |
3.05338 |
[BP] GO:0034766 |
None
|
ADRA2A, DRD2, DRD3, KCNH2, MMP9, PRKCE |
3.05062 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B |
3.04886 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, ESR1, FLT3, HTR1A, MET, PIK3CB, PIM1, POLA1, PRKCD, SRC, TYR |
3.03279 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP2D6, DRD1, DRD2, DRD3, ESR1, F10, F3, FLT3, FUT7, GBA2, GLO1, HTR1A, HTR2B, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
3.03188 |
[BP] GO:0051234 |
None
|
ACHE, ADORA1, ADRA1A, ADRA2A, ALOX5, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, DRD3, F10, FABP3, HTR2A, HTR2B, KCNH2, MMP12, MMP9, PPARA, PRKCB, PRKCD, PRKCE, SIGMAR1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SLC6A2, SLC6A4, SRC, TERT, TNKS, TRPV1, XDH |
3.03188 |
[BP] GO:0051302 |
None
|
AURKB, CDC25B, DRD2, DRD3, ESRRB, HTR2B, PRKCE |
3.03182 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, PIK3CB, PRKCB, PRKCE, TRPV1 |
3.02359 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, ADRA2A, BCL2, HCAR2, HTR2B, MET, PIK3CA, PPARA, PRKCG |
3.01557 |
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, ADRA2A, CYP19A1, DRD2, HCAR2, HTR1A, HTR2A, PRKCA, PRKCE |
3.01557 |
[BP] GO:0003014 |
None
|
ADORA1, ADRA1A, AKR1B1, BCL2, DRD2, HSD11B2 |
3.01283 |
[BP] GO:0097553 |
None
|
DRD2, HTR2A, HTR2B, PRKCE, TRPV1 |
3.00279 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP2D6, FABP3, FABP4, FUT7, GBA2, MMP1, MMP12, MMP2, MMP9, PIK3CB, SRC, XDH |
2.99908 |
[BP] GO:0043266 |
None
|
ADORA1, ADRA2A, DRD1, DRD2, HTR2A, KCNH2 |
2.96543 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, BCL2, MET, MMP9, PPARA, PRKCD, SRC, TERT |
2.94548 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALPL, AXL, BCL2, CA2, CDK6, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FLT3, GBA2, HSD11B1, HSD17B2, HTR5A, KDR, MMP9, PIK3CA, PIM1, POLB, PPARA, PTGS2, RORC, SIGMAR1, SRC, TYR |
2.94073 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, ADRA2A, FLT3, HTR2A, HTR2B, IGF1R, PIK3CB, PRKCD, PTPN1, SRC |
2.93804 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TERT, TNKS, TNKS2 |
2.93804 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, HTR2A, PTGS2 |
2.93804 |
[BP] GO:0001775 |
cell activation
|
ADRA2A, ALOX5, AXL, BCL2, FLT3, FUT7, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, RORC, SRC, TRPV1 |
2.92813 |
[BP] GO:0019935 |
None
|
ADRA1A, ADRA2A, DRD1, DRD2, DRD3, HTR5A |
2.92684 |
[BP] GO:0034763 |
None
|
ADRA2A, DRD2, DRD3, KCNH2, MMP9, PRKCE |
2.92684 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PTPN1, SRC |
2.92195 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA1A, ADRA2A, BCL2, CDC25B, CSNK2A1, DRD2, ESR1, F3, FLT3, HTR2A, HTR2B, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
2.91713 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, MMP9, PRKCD, PTGS1, PTGS2, SRC |
2.91659 |
[BP] GO:0051098 |
regulation of binding
|
AURKB, BCL2, CYP2D6, MET, MMP9, PPARA, PRKCD, SRC, TERT, TNKS |
2.91659 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, F10, F3, MET, PIK3CA, PIK3CB, SRC |
2.88948 |
[BP] GO:0007154 |
None
|
ADORA1, ADRA1A, AXL, BCL2, CHRM2, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7, PRKCG, PTGS2, SLC6A2, TRPV1 |
2.88642 |
[BP] GO:0035265 |
organ growth
|
ADRA1A, BCL2, CYP19A1, ESR1 |
2.88575 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, PRKCD |
2.88575 |
[BP] GO:0048015 |
phosphatidylinositol-mediated signaling
|
HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB |
2.88575 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRA2A, AKR1B1, APEX1, DRD1, ESR1, FLT3, IGF1R, MMP2, PRKCD, PRKCE, PTGS2, SLC6A4, SRC, TRPV1 |
2.86486 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, FABP3, HSD11B2, IGF1R, PPARA, PRKCD, PTGS2, SRC, TRPV1 |
2.86448 |
[BP] GO:0045766 |
positive regulation of angiogenesis
|
CYP1B1, F3, KDR, PRKCA, PRKCB, PTGS2, TERT |
2.86267 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, ADRA2A, AURKB, CDC25B, DRD2, FLT3, HTR2A, HTR2B, PIK3CA, PIK3CB, PRKCD, PTPN1, SRC, TNKS |
2.85573 |
[BP] GO:0045744 |
None
|
ADRA2A, DRD2, DRD3, MET |
2.83845 |
[BP] GO:0031329 |
regulation of cellular catabolic process
|
ADRA2A, APEX1, BCL2, ESRRB, HTR2A, HTR2B, KDR, MET, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCG, PTPN1 |
2.82853 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, ADRA2A, CDC25B, DRD2, FLT3, HTR2A, HTR2B, PIK3CA, PIK3CB, PRKCD, PTPN1, SRC |
2.82009 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA1A, ADRA2A, BCL2, CDC25B, DRD2, ESR1, F3, FLT3, HTR2A, HTR2B, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
2.81892 |
[BP] GO:0002031 |
None
|
DRD2, DRD3, HTR2B |
2.81729 |
[BP] GO:0019371 |
None
|
PTGS1, PTGS2, TBXAS1 |
2.81729 |
[BP] GO:0010959 |
None
|
ADORA1, ADRA2A, BCL2, DRD1, DRD2, DRD3, HTR2A, KCNH2, PRKCE, PTGS2 |
2.8157 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRA1A, ADRA2A, BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, XDH |
2.8139 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA1A, ADRA2A, AURKB, BCL2, CDC25B, DRD2, ESR1, F3, FLT3, HTR2A, HTR2B, PIK3CA, PIK3CB, PRKCD, PRKCE, PTPN1, SRC, TERT, TNKS, XDH |
2.80875 |
[BP] GO:0046889 |
None
|
FABP3, HTR2A, HTR2B, PRKCD, PTGS2 |
2.80875 |
[BP] GO:0006855 |
None
|
SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2 |
2.80875 |
[BP] GO:0048017 |
inositol lipid-mediated signaling
|
HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB |
2.80875 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6 |
2.80228 |
[BP] GO:0007194 |
None
|
ADRA2A, DRD2, DRD3, PRKCA |
2.80228 |
[BP] GO:0043278 |
None
|
DRD2, DRD3, PRKCE, PRKCG |
2.80228 |
[BP] GO:0014072 |
None
|
DRD2, DRD3, PRKCE, PRKCG |
2.80228 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRA1A, ADRA2A, CHRM2, DRD2, HTR2A, KCNH2, PTGS2 |
2.80158 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
AURKB, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2A, HTR2B, IGF1R, MET, MMP12, PPARA, PRKCD, PTGS2, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1 |
2.79076 |
[BP] GO:0006940 |
None
|
ADORA1, ADRA1A, ADRA2A, CHRM2, PTGS2 |
2.78697 |
[BP] GO:0035408 |
None
|
PRKCA, PRKCB |
2.78064 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.78064 |
[BP] GO:0006286 |
base-excision repair, base-free sugar-phosphate removal
|
APEX1, POLB |
2.78064 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.76489 |
[BP] GO:0007268 |
None
|
CHRM2, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7, PRKCG, SLC6A2 |
2.73767 |
[BP] GO:0098916 |
None
|
CHRM2, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7, PRKCG, SLC6A2 |
2.73767 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
BCL2, DRD2, DRD3, PIK3CA, TNKS2 |
2.73767 |
[BP] GO:1900076 |
regulation of cellular response to insulin stimulus
|
ESRRA, PRKCB, PRKCD, PTPN1, SRC |
2.73767 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2A6, CYP2C19 |
2.73257 |
[BP] GO:0015697 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
2.73257 |
[BP] GO:0031280 |
None
|
ADRA2A, DRD2, DRD3, PRKCA |
2.7222 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, APEX1, AURKB, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, HCAR2, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PIM1, POLA1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH |
2.71895 |
[BP] GO:0045913 |
None
|
ESRRB, HTR2A, PPARA, PRKCE, SRC |
2.71505 |
[BP] GO:0032465 |
None
|
AURKB, CDC25B, DRD2, DRD3, PRKCE |
2.71505 |
[BP] GO:0051282 |
None
|
DRD1, DRD2, HTR2A, HTR2B, PRKCE, TRPV1 |
2.70009 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, ADRA2A, CA2, DRD2, DRD3, HCAR2, HTR2B, MMP12, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC |
2.69797 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
2.69482 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, ADRA2A, DRD2, DRD3, HCAR2, HTR2B, MMP12, PRKCA, PRKCE, SRC |
2.68859 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, HTR6 |
2.67988 |
[BP] GO:0099536 |
None
|
CHRM2, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7, PRKCG, SLC6A2 |
2.67635 |
[BP] GO:0099537 |
None
|
CHRM2, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7, PRKCG, SLC6A2 |
2.67635 |
[BP] GO:0050730 |
None
|
ADORA1, ADRA2A, FLT3, HTR2A, PRKCD, PRKCE, PTPN1, SRC |
2.66792 |
[BP] GO:1900274 |
regulation of phospholipase C activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.63994 |
[BP] GO:0051350 |
None
|
ADRA2A, DRD2, DRD3, PRKCA |
2.63994 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.63994 |
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3 |
2.63994 |
[BP] GO:1900543 |
None
|
ADRA2A, DRD2, DRD3, PPARA, PRKCA |
2.63994 |
[BP] GO:1900542 |
None
|
ADRA2A, DRD1, DRD2, DRD3, ESRRB, HTR2A, PPARA, PRKCA |
2.63555 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRA1A, ADRA2A, DRD1, DRD2, DRD3, HTR2B, HTR5A, KDR |
2.6235 |
[BP] GO:0006812 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, KCNH2, PRKCB, PRKCE, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC6A2, SLC6A4, TRPV1 |
2.61827 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, ADRA2A, CDC25B, DRD2, FLT3, HTR2A, HTR2B, PIK3CA, PIK3CB, PRKCD, PTPN1, SRC |
2.61775 |
[BP] GO:0045980 |
None
|
ADRA2A, DRD2, DRD3, PPARA, PRKCA |
2.61775 |
[BP] GO:0007189 |
None
|
ADRA1A, ADRA2A, DRD1, DRD2, DRD3 |
2.61775 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, KDR, PIK3CA, PIK3CB, SRC |
2.61775 |
[BP] GO:1904018 |
positive regulation of vasculature development
|
CYP1B1, F3, KDR, PRKCA, PRKCB, PTGS2, TERT |
2.58735 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KDR, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, PRKCD, SRC |
2.58398 |
[BP] GO:0015695 |
None
|
SLC22A1, SLC22A2, SLC22A3, SLC47A1 |
2.55793 |
[BP] GO:0006140 |
None
|
ADRA2A, DRD1, DRD2, DRD3, ESRRB, HTR2A, PPARA, PRKCA |
2.5565 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.55271 |
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3 |
2.55271 |
[BP] GO:0051967 |
None
|
ADORA1, DRD2, HTR2A |
2.55271 |
[BP] GO:0032413 |
None
|
ADRA2A, DRD2, DRD3, MMP9, PRKCE |
2.5413 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, PTGS2, TERT |
2.51463 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, ESR1, ESRRA, HTR5A, PTGS2, SLC6A4 |
2.50682 |
[BP] GO:0051726 |
regulation of cell cycle
|
APEX1, AURKB, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, DRD2, DRD3, PIM1, PRKCA, PRKCE, PTGS2, SLC6A4, SRC, TERT, TNKS, TOP2A |
2.50374 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, DRD1, IGF1R, MMP2, PRKCD, PTGS2, SLC6A4, SRC, TRPV1 |
2.50374 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6 |
2.49133 |
[BP] GO:0010038 |
response to metal ion
|
BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, MMP9, PTGS2, TERT |
2.48969 |
[BP] GO:0007204 |
positive regulation of cytosolic calcium ion concentration
|
ADRA1A, DRD1, DRD2, ESR1, HTR2A, HTR2B, PRKCE, TRPV1 |
2.48116 |
[BP] GO:0050965 |
None
|
ADORA1, HTR2A, TRPV1 |
2.47033 |
[BP] GO:0050961 |
None
|
ADORA1, HTR2A, TRPV1 |
2.47033 |
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3 |
2.47033 |
[BP] GO:0070198 |
None
|
TERT, TNKS, TNKS2 |
2.47033 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, HSD17B2, KDR, MMP2, PRKCE, PTGS2, SLC6A4, SRC |
2.46437 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, PRKCD, SRC |
2.44195 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA1A, ADRA2A, BCL2, DRD2, DRD3, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, PRKCB, PRKCD, PTGS2, PTPN1, SRC, TERT, XDH |
2.4303 |
[BP] GO:0015850 |
None
|
DRD1, SLC22A1, SLC22A2, SLC22A3, SLC6A2, SLC6A4 |
2.42594 |
[BP] GO:0045776 |
None
|
ADORA1, DRD2, DRD3, PPARA |
2.40835 |
[BP] GO:0043268 |
None
|
ADORA1, ADRA2A, DRD1, KCNH2 |
2.40835 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, DRD2, HCAR2, HTR2B, MMP12, PRKCE, SRC |
2.40835 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, PRKCD, SRC |
2.40407 |
[BP] GO:2000811 |
negative regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.39431 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B |
2.39431 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.39431 |
[BP] GO:0051051 |
negative regulation of transport
|
ADORA1, ADRA2A, BCL2, DRD2, DRD3, HTR2A, KCNH2, MMP9, PRKCB, PRKCE, PTGS2 |
2.38758 |
[BP] GO:0098502 |
DNA dephosphorylation
|
APEX1, POLB |
2.38758 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.38758 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.38758 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.38758 |
[BP] GO:0032227 |
negative regulation of synaptic transmission, dopaminergic
|
PTGS2, SLC6A4 |
2.38758 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.387 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.387 |
[BP] GO:0032410 |
None
|
ADRA2A, DRD2, DRD3, MMP9, PRKCE |
2.36953 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, PRKCD, SRC |
2.35264 |
[BP] GO:0030818 |
None
|
ADRA2A, DRD2, DRD3, PRKCA |
2.35107 |
[BP] GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress
|
BCL2, CYP1B1, PRKCD |
2.33555 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.33555 |
[BP] GO:0001504 |
None
|
SLC22A3, SLC6A2, SLC6A4 |
2.33555 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, ADRA2A, FLT3, HTR2A, HTR2B, PIK3CB, PTPN1, SRC |
2.33324 |
[BP] GO:0007623 |
circadian rhythm
|
DRD2, DRD3, HTR7, PPARA, RORC, SLC6A4 |
2.33221 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, ADRA2A, CDC25B, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB, PRKCD, PTPN1, SRC |
2.32395 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ADRA1A, DRD2, HTR2A, HTR2B, KDR, PRKCA, SRC |
2.32319 |
[BP] GO:0045761 |
None
|
ADRA2A, DRD2, DRD3, PRKCA |
2.32319 |
[BP] GO:0050708 |
None
|
ACHE, ADRA2A, DRD2, DRD3, HCAR2, HTR2B, MMP12, PRKCA, PRKCE, SRC |
2.29816 |
[BP] GO:0042136 |
neurotransmitter biosynthetic process
|
ACHE, CYP1B1, SLC22A2, SLC6A4 |
2.28815 |
[BP] GO:0030803 |
None
|
ADRA2A, DRD2, DRD3, PRKCA |
2.28815 |
[BP] GO:0023052 |
None
|
ADORA1, ADRA1A, CHRM2, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7, KCNH2, PRKCG, SLC6A2 |
2.2872 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2 |
2.27378 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APEX1, DRD1, IGF1R, MMP2, PRKCD, PTGS2, SLC6A4, SRC, TRPV1 |
2.27103 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.27103 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR2B |
2.27103 |
[BP] GO:0042133 |
neurotransmitter metabolic process
|
ACHE, CYP1B1, HTR1A, SLC22A2, SLC6A4 |
2.27103 |
[BP] GO:0060359 |
None
|
DRD1, DRD2, DRD3, PRKCE, PRKCG |
2.27103 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
BCL2, CYP1B1, F3, HCAR2, MMP9, PIK3CB, PRKCD, PTGS2, SRC, TOP2A, TRPV1, XDH |
2.26319 |
[BP] GO:0050433 |
None
|
ADRA2A, DRD2, DRD3, HTR2A |
2.25918 |
[BP] GO:0050890 |
None
|
ADORA1, DRD1, DRD2, DRD3, HTR2A, PRKCG, PTGS2, SLC6A4 |
2.25865 |
[BP] GO:2001023 |
None
|
DRD1, DRD2, DRD3, HTR2A, MET |
2.25125 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CYP1A1, HSD11B2, PTGS2, SLC6A4, SRC, TRPV1, TYR |
2.24428 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, ADRA2A, AURKB, CDC25B, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB, PRKCD, PTPN1, SRC, TNKS |
2.24428 |
[BP] GO:0090068 |
positive regulation of cell cycle process
|
APEX1, AURKB, CDC25B, CYP1A1, DRD2, DRD3, PRKCE, TERT |
2.24105 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ADRA1A, DRD2, HTR2A, HTR2B, KDR, PRKCA, PTPN1, SRC |
2.24105 |
[BP] GO:0051588 |
None
|
DRD1, DRD2, DRD3, HTR1A, SLC6A4 |
2.23258 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
BCL2, CYP1B1, F3, HCAR2, MMP9, PIK3CB, PRKCD, PTGS2, SRC, TOP2A, TRPV1, XDH |
2.23109 |
[BP] GO:0030815 |
None
|
ADRA2A, DRD2, DRD3, PRKCA |
2.2309 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
APEX1, CDC25B, CYP1A1, DRD3, PRKCA, TERT |
2.21754 |
[BP] GO:0043279 |
None
|
DRD2, DRD3, PRKCE, PRKCG, TRPV1 |
2.2133 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.21201 |
[BP] GO:0016048 |
None
|
ADORA1, HTR2A, TRPV1 |
2.21201 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.21201 |
[BP] GO:0040011 |
locomotion
|
AXL, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KDR, MET, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, PRKCD, SRC |
2.20966 |
[BP] GO:0048870 |
cell motility
|
AXL, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KDR, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, PRKCD, SRC |
2.20894 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRA1A, ADRA2A, APEX1, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, HCAR2, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PIM1, POLA1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH |
2.20875 |
[BP] GO:0043434 |
None
|
APEX1, FABP3, HSD11B2, PPARA, PRKCD, PTGS2, SRC, TRPV1 |
2.20796 |
[BP] GO:1900372 |
None
|
ADRA2A, DRD2, DRD3, PRKCA |
2.20662 |
[BP] GO:0030809 |
None
|
ADRA2A, DRD2, DRD3, PRKCA |
2.20662 |
[BP] GO:0046626 |
regulation of insulin receptor signaling pathway
|
PRKCB, PRKCD, PTPN1, SRC |
2.20662 |
[BP] GO:0010518 |
positive regulation of phospholipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.20662 |
[BP] GO:1903532 |
None
|
ACHE, CYP19A1, DRD2, HCAR2, HTR2B, MMP12, PRKCE, SLC6A4, SRC |
2.20366 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, ADRA2A, BCL2, CSNK2A1, DRD2, DRD3, HCAR2, HTR2B, MMP12, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TERT |
2.19778 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, APEX1, AURKB, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, GLO1, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PIM1, POLA1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH |
2.18893 |
[BP] GO:0030800 |
None
|
ADRA2A, DRD2, DRD3, PRKCA |
2.17634 |
[BP] GO:0070201 |
None
|
ACHE, ADRA2A, BCL2, DRD2, DRD3, HCAR2, HTR2B, MMP12, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC |
2.16403 |
[BP] GO:0007267 |
None
|
ADORA1, ADRA1A, CHRM2, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7, PRKCG, SLC6A2 |
2.16403 |
[BP] GO:0009896 |
positive regulation of catabolic process
|
ADRA2A, CSNK2A1, ESRRB, HTR2A, KDR, PIK3CB, PPARA, PRKCD, PRKCE, PTPN1 |
2.16206 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.15961 |
[BP] GO:0071880 |
None
|
ADRA1A, ADRA2A, DRD2 |
2.15961 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
AURKB, IGF1R, PRKCD, PRKCG, SRC, TNKS, TNKS2 |
2.15333 |
[BP] GO:0051480 |
regulation of cytosolic calcium ion concentration
|
ADRA1A, DRD1, DRD2, ESR1, HTR2A, HTR2B, PRKCE, TRPV1 |
2.15111 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, MMP9, PTGS2, PTPN1, SRC |
2.15111 |
[BP] GO:1901374 |
None
|
SLC22A1, SLC22A2 |
2.15111 |
[BP] GO:0033031 |
positive regulation of neutrophil apoptotic process
|
HCAR2, PIK3CB |
2.15111 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.15111 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.15111 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.15111 |
[BP] GO:0010632 |
regulation of epithelial cell migration
|
KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC |
2.13637 |
[BP] GO:0010676 |
None
|
ESRRB, PPARA, PRKCE, SRC |
2.12503 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
AURKB, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, HTR2A, IGF1R, MET, MMP12, PPARA, PRKCD, PRKCG, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A |
2.11883 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.10713 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.10713 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.09749 |
[BP] GO:0030817 |
None
|
ADRA2A, DRD1, DRD2, DRD3, PRKCA |
2.09608 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, FLT3, HSD11B2, PTGS2, SRC |
2.09436 |
[BP] GO:0009605 |
response to external stimulus
|
ADORA1, ADRA1A, ALPL, AXL, BCL2, CDK6, CHRM2, CYP1A1, CYP1A2, DRD3, HSD11B2, HTR2A, MMP12, PRKCD, PTGS2, SLC6A4, SRC, TRPV1, TYR |
2.08978 |
[BP] GO:0051100 |
negative regulation of binding
|
AURKB, CYP2D6, MET, PPARA, PRKCD, TNKS |
2.08306 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, FLT3, HSD11B2, PTGS2, SRC |
2.08306 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, AXL, BCL2, CA2, CDK6, CYP19A1, DRD2, ESR1, ESRRA, HCAR2, MMP12, MMP2, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTPN1, SRC |
2.06301 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, ADRA2A, CDC25B, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB, PRKCD, PTPN1, SRC |
2.05832 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.05832 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.05832 |
[BP] GO:0050995 |
None
|
ADORA1, ADRA2A, HCAR2 |
2.05832 |
[BP] GO:0050996 |
None
|
PPARA, PRKCD, PRKCE |
2.05832 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, APEX1, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PIM1, POLA1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH |
2.04976 |
[BP] GO:0031623 |
None
|
ACHE, DRD2, DRD3, HTR2B |
2.04876 |
[BP] GO:0032922 |
None
|
DRD2, DRD3, PPARA, RORC |
2.04876 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.01773 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CDK6, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GLO1, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SIGMAR1, SLC22A1, SLC22A2, SLC22A3, SLC6A2, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH |
2.01054 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, CDK6, KDR, PIK3CB, SRC |
2.01054 |
[BP] GO:0051953 |
None
|
ADORA1, ADRA2A, DRD2 |
2.00689 |
[BP] GO:2000209 |
regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.00689 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.00689 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.00689 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, ALOX5, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, F10, F3, FLT3, FUT7, GBA2, GLO1, HCAR2, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, MMP2, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, SIGMAR1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SLC6A2, SLC6A4, SRC, TBXAS1, TERT, TNKS, TNKS2, TRPV1, TYR |
7.15366 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CHRM2, CSNK2A1, DRD1, DRD2, DRD3, ESR1, F10, F3, FLT3, GBA2, GLO1, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, MMP2, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SLC6A2, SLC6A4, SRC, TERT, TRPV1 |
7.10338 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AXL, CA4, CHRM2, DRD1, DRD2, DRD3, F10, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, SLC22A1, SLC22A2, SLC22A3, SLC6A2, SLC6A4, TRPV1 |
6.67645 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AXL, CHRM2, DRD1, DRD2, DRD3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, SLC22A1, SLC22A2, SLC22A3, SLC6A2, SLC6A4, TRPV1 |
5.3617 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, F10, F3, FLT3, FUT7, GBA2, HCAR2, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, MPEG1, PIK3CA, PIK3CB, PRKCG, PTGS1, PTGS2, PTPN1, SIGMAR1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SLC6A2, SLC6A4, SRC, TBXAS1, TRPV1, TYR |
4.942 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
BCL2, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, F10, FLT3, GBA2, HSD11B1, HSD11B2, HSD17B2, PTGS1, PTGS2, PTPN1, SIGMAR1, TBXAS1 |
4.3423 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AXL, CA2, CA4, CA9, CHRM2, DRD1, DRD2, DRD3, F10, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, PRKCG, PTGS2, SIGMAR1, SLC22A1, SLC22A2, SLC22A3, SLC6A2, SLC6A4, SRC, TRPV1 |
4.27508 |
[CC] GO:0005783 |
None
|
ADORA1, APEX1, BCL2, CA4, CES1, CES2, CYP19A1, CYP2D6, FLT3, GBA2, HTR5A, KDR, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SIGMAR1, XDH |
4.10525 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, ADRA1A, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, AURKB, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA7, CDC25B, CDK6, CES1, CES2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, F10, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR2A, HTR5A, KCNH2, KDR, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, SIGMAR1, SLC6A4, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH |
3.76112 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, GBA2, HSD11B1, HSD11B2, HSD17B2, PTGS1, PTGS2, SIGMAR1, TBXAS1 |
3.68001 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, ADRA1A, ADRA2A, CA2, CA4, CA9, CHRM2, DRD1, DRD2, HTR2A, MET, PRKCG, PTGS2, SIGMAR1, SLC22A1, SRC, TRPV1 |
2.84448 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.15961 |
[CC] GO:0044464 |
cell part
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA7, CA9, CDC25B, CDK6, CES1, CES2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SIGMAR1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SLC6A2, SLC6A4, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH |
2.10274 |
[CC] GO:0048471 |
perinuclear region of cytoplasm
|
ACHE, AKR1B1, APEX1, CA4, KCNH2, PRKCA, PRKCD, PRKCE, PRKCG, SRC, TNKS2, TYR |
2.06376 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, PPARA, PRKCA, PRKCB, PRKCG, PTPN1, RORC, TBXAS1, TNKS, TYR, XDH |
18.335 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GLO1, HSD17B1, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH |
15.5445 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
15.4667 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, GLO1, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, POLA1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, TBXAS1, TERT, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH |
14.8103 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, F10, F3, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
11.8206 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, POLB |
10.9211 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CDK6, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SIGMAR1, SLC6A4, SRC, TOP2A, TRPV1 |
9.8385 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, PPARA, PRKCA, PRKCB, PRKCG, PTPN1, RORC, TNKS |
9.70431 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, F10, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, POLA1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, TBXAS1, TERT, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH |
9.65273 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
9.47768 |
[MF] GO:0008227 |
None
|
ADRA1A, ADRA2A, CHRM2, DRD2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
9.37687 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGS1, PTGS2, SRC, TBXAS1 |
8.46471 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, SLC6A4 |
8.34426 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, HSD11B1, HSD11B2, HSD17B1, HSD17B2, NQO2, PTGS1, PTGS2, TBXAS1, TYR, XDH |
8.33326 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGS1, PTGS2, SRC, TBXAS1 |
8.12207 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, GLO1, POLB |
7.91121 |
[MF] GO:0005329 |
None
|
SLC22A1, SLC22A2, SLC22A3, SLC6A2, SLC6A4 |
7.90228 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AXL, CHRM2, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, PPARA, RORC, SIGMAR1, TRPV1 |
7.8367 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGS1, PTGS2, TBXAS1, TYR |
7.66726 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
7.56355 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, TBXAS1, XDH |
7.5592 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, TBXAS1, TYR |
7.4194 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, HSD11B2, HSD17B1, NQO2, POLA1, PTGS1, PTGS2, SRC, TBXAS1, XDH |
7.36293 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AXL, CDK6, CHRM2, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, PPARA, RORC, SIGMAR1, TRPV1 |
7.06376 |
[MF] GO:0030594 |
None
|
CHRM2, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.90322 |
[MF] GO:0008504 |
None
|
SLC22A1, SLC22A2, SLC22A3, SLC6A2, SLC6A4 |
6.81674 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AXL, CHRM2, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, PPARA, RORC, SIGMAR1, TRPV1 |
6.77101 |
[MF] GO:0099528 |
None
|
CHRM2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.49693 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AXL, CHRM2, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, PPARA, PRKCE, RORC, SIGMAR1, TRPV1 |
6.46301 |
[MF] GO:0043176 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.35317 |
[MF] GO:0051378 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.35317 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
6.32098 |
[MF] GO:0004993 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.23108 |
[MF] GO:0099589 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.23108 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, CYP2D6 |
6.05171 |
[MF] GO:0004697 |
None
|
PRKCA, PRKCB, PRKCD, PRKCE, PRKCG |
5.52373 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP2C19, CYP2D6 |
5.37466 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIK3CA, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
4.89091 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TERT |
4.80837 |
[MF] GO:0005333 |
None
|
SLC22A1, SLC22A2, SLC6A2 |
4.70171 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AXL, CHRM2, DRD1, DRD2, DRD3, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, TRPV1 |
4.53899 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AXL, CHRM2, DRD1, DRD2, DRD3, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, TRPV1 |
4.53899 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
4.52852 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.50686 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.50686 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, PIK3CA, PIK3CB, PRKCD |
4.50686 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
4.3668 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, RORC |
4.31772 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, ADRA2A, AOX1, APEX1, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD11B2, HSD17B1, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, KDR, MET, MMP12, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC6A4, SRC, TBXAS1, TERT, TOP2A, TRPV1, XDH |
4.29126 |
[MF] GO:0008519 |
None
|
SLC22A1, SLC22A2, SLC22A3, SLC6A2, SLC6A4 |
4.23444 |
[MF] GO:0004698 |
None
|
PRKCA, PRKCB, PRKCG |
4.20418 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
4.10125 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.09626 |
[MF] GO:0015238 |
None
|
SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SLC6A2, SLC6A4 |
4.09499 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
4.06086 |
[MF] GO:1901338 |
None
|
ADRA2A, DRD1, DRD2, DRD3 |
3.50958 |
[MF] GO:1901618 |
None
|
SLC22A1, SLC22A2, SLC22A3, SLC6A2, SLC6A4 |
3.44237 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ADORA1, AOX1, APEX1, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD11B2, HSD17B1, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, KDR, MET, MMP12, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC6A4, SRC, TBXAS1, TERT, TOP2A, TRPV1, XDH |
3.06528 |
[MF] GO:0015651 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
3.04886 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.03502 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
2.92963 |
[MF] GO:0008289 |
lipid binding
|
AXL, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA, RORC, TRPV1 |
2.90433 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, AOX1, BCL2, CSNK2A1, DRD2, ESR1, ESR2, FLT3, IGF1R, KCNH2, KDR, MET, MMP9, NQO2, PTGS2, SLC22A1, SLC6A4, TERT, TOP2A, TRPV1, TYR, XDH |
2.89227 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, ADRA1A, ADRA2A, CHRM2, DRD1, DRD2, DRD3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
2.8792 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.85723 |
[MF] GO:0009931 |
None
|
PRKCA, PRKCB, PRKCG |
2.81729 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, ADRA2A, APEX1, CSNK2A1, ESRRB, FLT3, HTR2A, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SLC6A4, SRC |
2.80875 |
[MF] GO:0042803 |
protein homodimerization activity
|
ACHE, ADRA2A, AOX1, BCL2, DRD2, FLT3, KCNH2, NQO2, PTGS2, SLC22A1, SLC6A4, TERT, TOP2A, TYR, XDH |
2.78832 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ADRA2A, APEX1, ESRRB, FLT3, HTR2A, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC |
2.78832 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, NQO2, XDH |
2.78697 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.78064 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.78064 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.78064 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.78064 |
[MF] GO:0035403 |
None
|
PRKCA, PRKCB |
2.78064 |
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3 |
2.73257 |
[MF] GO:0010857 |
None
|
PRKCA, PRKCB, PRKCG |
2.73257 |
[MF] GO:0019899 |
enzyme binding
|
ADRA2A, AURKB, BCL2, CDC25B, CYP1A1, CYP1A2, CYP2A6, CYP2C19, ESR1, ESR2, ESRRB, F3, KCNH2, MET, POLA1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SLC6A4, SRC, TNKS2, TOP2A |
2.67635 |
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3 |
2.63994 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
2.59672 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, PRKCD, SRC |
2.50475 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.44669 |
[MF] GO:0004935 |
None
|
ADRA1A, ADRA2A, DRD2 |
2.39431 |
[MF] GO:0015307 |
None
|
SLC47A1, SLC47A2 |
2.38758 |
[MF] GO:1901375 |
None
|
SLC22A1, SLC22A2 |
2.38758 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A4 |
2.38758 |
[MF] GO:0005277 |
None
|
SLC22A1, SLC22A2 |
2.38758 |
[MF] GO:0008513 |
None
|
SLC22A1, SLC22A2 |
2.38758 |
[MF] GO:0004699 |
None
|
PRKCD, PRKCE |
2.38758 |
[MF] GO:0047374 |
None
|
CES1, CES2 |
2.38758 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.35107 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AOX1, AURKB, AXL, CDK6, CSNK2A1, FABP3, FABP4, FLT3, HSD11B2, HSD17B1, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A, TRPV1, XDH |
2.33926 |
[MF] GO:0008392 |
None
|
CYP2A13, CYP2A6, CYP2C19 |
2.33555 |
[MF] GO:0008391 |
None
|
CYP2A13, CYP2A6, CYP2C19 |
2.33555 |
[MF] GO:0035173 |
histone kinase activity
|
AURKB, PRKCA, PRKCB |
2.33555 |
[MF] GO:0046983 |
protein dimerization activity
|
ACHE, ADORA1, ADRA1A, ADRA2A, AOX1, AXL, BCL2, DRD2, FLT3, KCNH2, NQO2, PTGS2, SLC22A1, SLC6A4, TERT, TOP2A, TYR, XDH |
2.17709 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.15961 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.15111 |
[MF] GO:0032795 |
None
|
ADORA1, ADRA2A |
2.15111 |
[MF] GO:0004674 |
protein serine/threonine kinase activity
|
AURKB, CDK6, CSNK2A1, PIK3CA, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG |
2.11405 |
[MF] GO:0000166 |
nucleotide binding
|
AOX1, AURKB, AXL, CDK6, CSNK2A1, FLT3, HSD11B2, HSD17B1, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A, TRPV1, XDH |
2.08985 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
AOX1, AURKB, AXL, CDK6, CSNK2A1, FLT3, HSD11B2, HSD17B1, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A, TRPV1, XDH |
2.08978 |
[MF] GO:0005326 |
None
|
SLC22A1, SLC22A2, SLC6A2, SLC6A4 |
2.07209 |